Biosensors has put in place a Group Whistleblowing Policy where concerns about possible improprieties in matters of financial reporting or other matters including any breach of the Code of Conduct can be reported on an anonymous basis and in confidence through an Ethics hotline channel managed by EthicsPoint, an independent external service provider.
The Group Whistleblowing Policy and the Ethics hotline channel (via internet or telephone) are put in place to encourage the raising of concerns in good faith.
Biosensors does not condone mischievous or malicious allegations.  Action may be taken against any person who files a report or provides evidence which he or she knows to be false, or without a reasonable belief in the truth and accuracy of such information.
Note: For individuals in the European Union, kindly note that local law may only permit reporting of certain issues (generally, suspected fraud and accounting, financial reporting and internal control matters).  Please evaluate the local legislation and/ or seek legal advice if necessary before making any reports.

Please refer to Biosensors Privacy Policy – (here for Italy).


Updated: December 2023

11881-000-EN - Rev.04

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors International representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, BMX-J® and RISE™ NC, are not available for sale in the United States and certain other countries. ALLEGRA™ is a product of NVT GmbH. Blue Sail Medical Co., Ltd is the ultimate parent company of NVT GmbH and Biosensors International Group, Ltd. and its subsidiaries are collaborating for the commercialization of the ALLEGRA™ device.

BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, BMX-J, Juno, S-Stent and Rise NC are trademarks or registered trademarks of Biosensors International Group, Ltd. ALLEGRA is a trademark or registered trademark of NVT AG. All other cited trademarks are the property of their respective owners.